Furqan Chishti is the founder of Klarovel, a peptide-protocol generation platform powered by a deterministic rules engine that personalizes protocols from health questionnaires and biomarker panels. He also runs Humnlabs, the parent biomarker-driven health-optimization platform serving globally. Topics: peptide pharmacology (GLP-1s, GH-axis peptides, tissue-repair compounds), the IGF-1 SDS framework for age- and sex-normalized dosing, peptide industry supply chain and quality control, longevity-tech architecture, and the safety case for rules engines versus LLMs in medical-information AI. Based in Oslo, Norway.